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Abstract A small 45 amino acid residue antifungal polypeptide
was isolated from the bark of spindle tree (Euonymus europaeus
L.). Though the primary structure of this so-called E. europaeus
chitin-binding protein or Ee-CBP is highly similar to the hevein
domain, it distinguishes itself from most previously identi¢ed
hevein-type antimicrobial peptides (AMP) by the presence of
two extra cysteine residues that form an extra disul¢de bond.
Due to these ¢ve disul¢de bonds Ee-CBP is a remarkably stable
protein. Agar di¡usion and microtiterplate assays demonstrated
that Ee-CBP is a potent antimicrobial protein. IC50-values as
low as 1 Wg/ml were observed for the fungus Botrytis cinerea.
Comparative assays further demonstrated that Ee-CBP is a
stronger inhibitor of fungal growth than Ac-AMP2 from Ama-
ranthus caudatus seeds, which is considered one of the most
potent antifungal hevein-type plant proteins.
/ 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Antimicrobial peptide; Bark; Hevein;
Spindle tree; Euonymus europaeus L.
1. Introduction
Plants accumulate many types of defense proteins in their
most vulnerable tissues to anticipate and cope with attacks
from di¡erent pests and pathogens. Some of these proteins
are induced by speci¢c biotic or abiotic agents, whereas others
are constitutively expressed. A particular group of such de-
fense-related proteins are the small cysteine-rich peptides with
antimicrobial properties. This group of so-called antimicrobial
peptides (AMPs) comprises di¡erent protein families like thi-
onins, plant defensins, lipid transfer proteins, hevein-type pep-
tides and knottin-type peptides [1^3]. Almost all these AMPs
possess four to eight cysteine residues forming two to four
disul¢de bonds that stabilize the overall fold of the polypep-
tide and contribute to the marked stability of the proteins.
Only snakin-1 (St-SN1), a recently discovered AMP of 63
amino acids from potato tubers [4] contains 12 cysteines
that form six disul¢de bridges. The number of disul¢de bonds
is not directly linked to the family to which the AMPs belong
but varies even within a single family. For example, within the
family of chitin-binding hevein-type polypeptides, proteins
have been identi¢ed with three (e.g. Ac-AMP), four (e.g. he-
vein) or ¢ve (e.g. Eucommia ulmoides AMPs) disul¢de bonds
[5^7].
This paper describes a novel hevein-type AMP from the
bark of spindle tree (Euonymus europaeus L.), a shrub of the
family Celastraceae, which is indigenous in Europe and is
characterized by green twigs and typical spindle-shaped red
fruits. The so-called E. europaeus chitin-binding protein, Ee-
CBP, is a hevein-type protein with a unique structure charac-
terized by the presence of 10 disul¢de bridge-linked cysteine
residues and an unusually high antifungal activity.
2. Materials and methods
2.1. Isolation and puri¢cation of Ee-CBP
A single spindle tree growing in a local forest (Egenhovenbos, He-
verlee, Belgium) was chosen for the collection of bark tissue. Bark was
removed (in February) from stems and twigs, chopped into small
pieces, freeze-dried and powdered in a co¡ee mill. The powder ob-
tained from 100 g of lyophilized bark was extracted in 1 l of 0.2 M
NaCl. The homogenate was cleared by centrifugation (8000Ug ; 10
min) and the supernatant loaded onto a column (5 cmU10 cm; ap-
proximately 200 ml bed volume) of chitin (Sigma-Aldrich, St. Louis,
MO, USA) pre-equilibrated with 0.2 M NaCl. After loading the ex-
tract, the column was washed with 0.2 M NaCl until the A280 fell
below 0.01 and the bound chitin-binding proteins eluted with 20 mM
acetic acid. The a⁄nity-puri¢ed fraction (which contains besides Ee-
CBP several other chitin-binding proteins) was dialyzed against 20
mM acetic acid for 48 h. Under these conditions the small-sized Ee-
CBP peptide migrates through the dialysis membrane (molecular
weight cuto¡ of 12^14 kDa, Medicell International, London, UK)
leaving behind the contaminating larger chitin-binding proteins. The
Ee-CBP fraction present in the dialysate was essentially pure and was
concentrated by a⁄nity chromatography on a smaller column (2.5
cmU5 cm; approximately 25 ml bed volume) of chitin. Approxi-
mately 10 mg of puri¢ed peptide was obtained from 100 g of lyophi-
lized bark tissue. Chitinase activity was assayed using carboxymethyl-
chitin-Remazol-brilliant-violet 5R as a substrate [8].
2.2. Amino acid sequence analysis and mass spectrometry of Ee-CBP
Ee-CBP was treated with pyroglutamate aminopeptidase (Roche
Diagnostics, Mannheim, Germany) to remove the blocked cyclic
N-terminal pyroglutamic acid [9]. N-terminal amino acid sequencing
was done on a pulsed liquid-phase 491 Procise-cLC protein sequencer
(Applied Biosystems, Foster City, CA, USA). To complete the amino
acid sequence of the peptide, reduced and alkylated (with iodacet-
amide) Ee-CBP was digested with the endoproteases Glu-C and trypsin
(both from Roche Diagnostics) according to Walker [9] and the frag-
ments separated by reverse-phase high-performance liquid chromatog-
raphy (RP-HPLC) on a C8 column (Aquapore RP-300) connected
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with an electrospray ion trap mass spectrometer (Esquire-LC, Bruker
Daltonic, Bremen, Germany). Peptide fragments were sequenced by
Edman degradation or by fragmentation on the mass spectrometer.
For relative molecular mass determination, native Ee-CBP and pro-
teolytic fragments were desalted on ZipTip, if required (Millipore,
Bedford, MA, USA) and injected on the ion trap mass spectrometer.
2.3. Determination of free thiol groups
To check the presence of free cysteines in Ee-CBP, 20 nmol of the
peptide was labeled with a 10-fold molar excess of the £uorescent
probe N-(1-pyrenyl)maleimide (PM) dissolved in N,N-dimethylforma-
mide as described by Bhattacharyya and Roy [10]. After labeling, the
protein was dissolved in sample bu¡er, separated by SDS^PAGE and
the presence of £uorescent free thiol groups checked on an UV-trans-
illuminator. An equal amount of reduced Ee-CBP served as a positive
control together with GNA, a lectin from Galanthus nivalis L. with
one free cysteine residue [11].
2.4. Assays for antimicrobial acivity
The antifungal activity of Ee-CBP was evaluated by agar di¡usion
assays (adapted from Schlumbaum et al. [12]). Mycelium plugs of ¢ve
phytopathogenic fungi (Alternaria brassicicola MUCL 20297, Botrytis
cinerea MUCL 6492, Fusarium culmorum IMI 180420, Neurospora
crassa FGSC 2489 and Phoma exigua CBS 431.74) were placed under
sterile conditions in the center of Petri dishes ¢lled with water agar
(1%). After 1^3 days (depending on the fungal growth rate at 22‡C)
di¡erent amounts of Ee-CBP were added into expunged holes equi-
distant from the mycelium plug.
In vitro microtiterplate assays (according to Broekaert et al. [13])
were used to compare the antimicrobial activity of Ee-CBP to that of
Ac-AMP2. Test fungi were the ¢ve aforementioned fungal strains,
Fusarium oxysporum f.sp. cubense and Mycosphaerella eumusae (two
tropical fungi isolated from Musa sp.), F. oxysporum f.sp. matthiolae
CBS 247.61, Phytophthora cryptogea CBS 418.71, Pythium ultimum
MUCL 30159, Rhizoctonia solani CBS 207.84 and Trichoderma hama-
tum ATCC 20765. Each well contained two-fold serial dilutions of 20
Wl ¢lter-sterilized AMP (500 Wg/ml) and 80 Wl of 1.6U104 fungal
spores/ml in half-strength PDB. The same protocol was followed for
the yeasts Pichia anomala strain K MUCL 40563 and Saccharomyces
cerevisiae strain Sp1 with 105 CFU. Bacterial strains tested were Ba-
cillus megaterium ATCC 13632, Sarcina lutea ATCC 9341, Erwinia
carotovora subsp. carotovora LMG 2458 and Ralstonia solanacearum
strain 2644, applied in 80 Wl of a soft agarose medium (tryptone 1%,
low melting point agarose 0.5%). Microbial growth inhibition was
quanti¢ed by measuring the A595.
3. Resuls and discussion
3.1. Isolation and characterization of Ee-CBP
A simple puri¢cation procedure based on a⁄nity chroma-
tography on chitin and selective permeation through a dialysis
membrane allowed purifying reasonable amounts of Ee-CBP.
The native protein yielded no signal upon N-terminal se-
quencing, indicating that it is N-terminally blocked. After
deblocking with pyroglutamate aminopeptidase a single se-
quence of 36 residues was obtained which shares a high sim-
ilarity/identity with previously sequenced or cloned hevein-
type AMPs. Calculations based on the di¡erence in molecular
mass between native Ee-CBP (4992.5 Da) and the polypeptide
comprising the ¢rst 36 residues (3973.4 Da) indicated approx-
imately 10 residues were still missing at the C-terminus. To
complete the sequence, reduced and alkylated Ee-CBP was
digested with Glu-C and the resulting fragments separated
by RP-HPLC. Two fragments were recovered. The peptide
eluting in the second peak corresponded to the ¢rst 29 resi-
dues, whereas that in the ¢rst peak yielded a unique sequence
of 16 residues starting with YCCTSQG (corresponding to
residues 30^45 of the intact polypeptide chain). Using this
seven-residue overlap the complete sequence of Ee-CBP could
be tentatively reconstructed. Sequencing of a peptide obtained
by tryptic digestion of reduced and alkylated Ee-CBP con-
¢rmed that the sequence in the overlap region between the
two Gly-C fragments was correct (Fig. 1A). Additional evi-
dence for the accuracy of the sequence was provided by mass
spectrometry of Ee-CBP. As shown in Fig. 2, Ee-CBP yielded
a minor component of 4992.9 Da, which matches exactly the
calculated molecular mass of the presumed 45 amino acid
polypeptide (taking into account the N-terminal pyroglutamic
acid) (4992.5 Da). The major peak in the mass spectrum (rep-
resenting 85% of the protein) corresponds to native Ee-CBP
without the C-terminal glycine residue. Based on these data,
one can reasonably assume that the sequence is correct.
Ee-CBP has a calculated iso-electric point of 11.81 and is
not glycosylated. The extinction coe⁄cient at 280 nm for a
1 mg/ml solution is 1.004.
Ee-CBP shares a high sequence identity/similarity with he-
vein and other hevein-type antifungal proteins (Fig. 1B) and
accordingly can be classi¢ed as a hevein-type AMP. All eight
cysteine residues present in hevein are conserved in Ee-CBP.
On the homology of hevein, one can reasonably assume that
these eight cysteine residues form four disul¢de bridges (be-
tween Cys3 and Cys18, Cys12 and Cys24, Cys17 and Cys31, and
Cys37 and Cys41, respectively). Surprisingly, Ee-CBP contains
two additional cysteine residues in its sequence at positions 32
and 44, respectively. To check whether these two cysteine
residues also form a disul¢de bond the possible presence of
free thiol groups was corroborated. Unreduced Ee-CBP was
treated with the £uorescent probe PM and subsequently ana-
lyzed by SDS^PAGE. The resulting polypeptide band yielded
no £uorescent signal upon exposure to UV light, whereas the
positive control proteins GNA and reduced Ee-CBP lighted
up as bright bands. It can be concluded, therefore, that no
free thiol groups are present in native Ee-CBP, and accord-
A
Ee-CBP  QQCGRQAGNRRCANNLCCSQYGYCGRTNEYCCTSQGCQSQCRRCG
B
Ee-CBP *QQCGRQAGNRRCANNLCCSQYGYCGRTNEYCCTSQGCQSQCRRCG
Hevein *EQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKDSG
Ac-AMP2 VGECVR****GRCPSGMCCSQFGYCGKGPKYCGR
Bv-IWF4 SGECNMY***GRCPPGYCCSKFGYCGVGRAYCG
EAFP1 *QTCASR*CPRPCNAGLCCSIYGYCGSGNAYCGA*GNCRCQCRG
Pn-AMP1 *QQCGRQASGRLCGNRLCCSQWGYCGSTASYCGA*G*CQSQCRS
        5            10           15           20           25           30            35           40           45
Trypsin
PAP
Glu-C
Fig. 1. A: Complete amino acid sequence of the mature Ee-CBP
obtained after digestion with pyroglutamate aminopeptidase and the
endoproteases Glu-C and trypsin. Fragments identi¢ed on the mass
spectrometer are underlined, whereas arrows indicate sequenced pep-
tide fragments. B: Sequence alignment of Ee-CBP in comparison
with other hevein-type antimicrobial peptides. The position of the
conserved cysteine residues (compared to hevein) is shaded in black.
Gray-shaded residues indicate the extra cysteine residues present in
Ee-CBP and EAFP1. The well-conserved amino acids shown in
bold are involved in chitin-binding activity. The disul¢de bridges are
indicated with full or dashed lines (Ee-CBP). Proteins shown in (B)
are hevein (from Hevea brasiliensis L. [6]) ; Ac-AMP2 (from Ama-
ranthus caudatus L. [5]); Bv-IWF4 (from Beta vulgaris L. [15]) ;
EAFP1 (from Eucommia ulmoides Oliv [7]) and Pn-AMP2 (from
Pharbitis nil L. [17]).
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ingly Cys32^Cys44 form a ¢fth disul¢de bridge (Fig. 1B). Tak-
ing into consideration the results of structural analysis of
hevein [6], which demonstrated that Cys32 is located close to
the C-terminus, the formation of an extra disul¢de bridge
between Cys32 and Cys44 of Ee-CBP is sterically allowed.
The absence of free thiol groups also explains the di¡erence
of 10 Da between the calculated molecular mass of reduced
Ee-CBP (5002.5 Da) and the measured value (4992.9. Da).
Enzymatic assays demonstrated that Ee-CBP is devoid of
both exo- and endochitinase activity, which indicates that the
puri¢ed protein is not contaminated by chitinases that may
interfere with the antifungal assays described below. Like all
hevein-type AMPs, Ee-CBP has a high a⁄nity for chitin and
accordingly can be puri¢ed by a⁄nity chromatography on
crude chitin.
3.2. Antimicrobial activity
To check whether Ee-CBP exhibits similar biological activ-
ities as the related hevein-type AMPs from other species the
antimicrobial activity of the novel spindle tree protein was
investigated. Agar di¡usion assays in Petri dishes indicated
that Ee-CBP possesses a very strong antifungal activity. The
growth of the phytopathogenic fungi B. cinerea and N. crassa
was inhibited at concentrations as low as 5 Wg/ml (Fig. 3A),
and that of the ascomycetes A. brassicicola and F. culmorum
at 10 Wg/ml. For the fungus P. exigua, a slightly higher con-
centration of Ee-CBP (25 Wg/ml) was required for growth in-
hibition (Fig. 3A). To better quantify the results, the inhibi-
tory activity of Ee-CBP was tested against a series of fungi in
a microtiterplate assay. As shown in Table 1, the results of
these microtiterplate assays are in good agreement with those
of the agar di¡usion assays (Fig. 3A). Microtiterplate assays
were also used to compare the antifungal activity of Ee-CBP
to that of Ac-AMP2 which is considered as one of the most
potent hevein-type antifungal polypeptides. According to the
data summarized in Table 1, Ee-CBP exhibits a stronger anti-
microbial activity than Ac-AMP2 towards most tested fungi.
For example, the IC50 of Ee-CBP is 16 and six-fold lower than
that of Ac-AMP2 for A. brassicicola and F. oxysporum sp.,
respectively. Only for the Deuteromycete P. exigua Ee-CBP
was slightly less active than Ac-AMP2. It is also noteworthy
that the IC50 for T. hamatum, an antagonistic fungus used in
biological control, was relatively high for Ee-CBP (as well as
for Ac-AMP2).
Most AMPs not only inhibit fungal growth but also a¡ect
the morphology of germinating spores and/or growing hy-
phae. To check whether Ee-CBP causes similar e¡ects the
morphology of di¡erent fungi grown in the presence and ab-
sence of the protein was compared. Microscopic analyses re-
Table 1
Comparison of the antimicrobial activity of Ee-CBP with Ac-AMP2
IC50(Wg/ml) Relative activity
Ee-CBP Ac-AMP2
Fungi
Alternaria brassicicolaa 3 50 16.7
Botrytis cinereaa 1 2 2
Fusarium culmoruma 3 6 2
Fusarium oxysporum f.sp. cubensea 15 100 6.7
Fusarium oxysporum f.sp. matthiolaea 5 30 6
Mycosphaerella eumusaea 6 8 1.3
Neurospora crassaa 2 3 1.5
Phoma exiguaa 33 30 0.9
Phytophthora cryptogeab 25 50 2
Pythium ultimuma 33 95 2.9
Rhizoctonia solanic 25 100 4
Trichoderma hamatuma 100 100 1
Gram-positive bacteria
Bacillus megateriumd 2 7 3.5
Sarcina lutead 7 20 2.9
The relative antimicrobial activity is expressed as (IC50 Ac-AMP2)/(IC50 Ee-CBP).
Concentration of protein required for 50% growth inhibition after incubation:
afor 48 h;
bfor 1 week;
cfor 96 h;
dand for 24 h;
Fig. 2. Mass spectrum of Ee-CBP and charge deconvolution dia-
gram indicating the total relative molecular mass of mature Ee-
CBP. The minor peak (15%) represents the intact protein, whereas
the major peak with molecular mass of 4936.2 Da (85%) corre-
sponds to a processing product lacking the C-terminal glycine resi-
due.
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vealed that Ee-CBP severely a¡ects the morphology of the test
fungi. Commonly observed e¡ects are bulbing, spore release,
hyphal branching and stunted growth (Fig. 3B). These micro-
scopic observations are in good agreement with the results
reported for hevein [14] and IWF4, an antifungal peptide
from beet leaves [15]. Besides fungi, Ee-CBP also inhibited
the growth of Gram-positive bacteria but not that of Gram-
negative bacteria and yeasts. Addition of mono- and divalent
cations like Kþ and Ca2þ to the medium resulted in a decrease
of the antifungal activity of Ee-CBP. In this respect, Ee-CBP
behaves like most of the previously described hevein-type
AMPs.
Ee-CBP is a markedly stable protein. The antifungal
activity is not a¡ected by boiling the peptide for 10 min
or by prolonged storage. Like most hevein-type AMPs,
Ee-CBP is stable over a wide pH range (from pH 2 to pH
11) [5].
At present, the mode of action of hevein-type AMPs is still
unclear. According to one hypothesis the compact folding of
the AMPs allows migration through the pores of the fungal
cell wall, enabling the peptides to interact with the plasma
membrane and impede fungal growth [7,14,16]. Another hy-
pothesis relates the antimicrobial activity to the highly basic
iso-electric point of hevein-type AMPs [5,15,17]. It is true that
Ee-CBP (pI 11.81), Ac-AMP1 (pI 10.25), Ac-AMP2 (pI
10.55), Bv-IWF4 (pI 9.76), both EAFPs (both with a pI of
11.14) as well as both Pn-AMPs (both with a pI of 12.01) are
all very basic proteins compared to hevein (pI 4.44). It should
be mentioned here that all iso-electric points have been calcu-
lated using the same software (http://www.up.univ-mrs.fr/cgi-
Fig. 3. E¡ect of Ee-CBP on fungal growth and morphology. A: Antibiosis of di¡erent fungi after incubation for 1 week at 22‡C in the pres-
ence of di¡erent concentrations of Ee-CBP (1^75 Wg/ml). Panels a^e show the e¡ect of Ee-CBP on the growth of A. brassicicola, B. cinerea,
F. culmorum, N. crassa and P. exigua, respectively. B: E¡ect of Ee-CBP on fungal morphology (magni¢cation 200U). Panels A and B show
stunted growth and hyperbranching of A. brassicicola and the normal growing fungus, respectively. Panels C and D display bulbed spores and
spore release of N. crassa and the una¡ected fungus, respectively.
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wabim/a-compo-p.pI) and assuming that all the cysteine resi-
dues are linked by disul¢de bonds. These calculated pI values
are in good agreement with the experimental values reported.
Since Ee-CBP possesses no exo-, nor endochitinase activity
the antifungal activity of the protein has to be ascribed most
likely to the high a⁄nity of the protein for chitin and oligo-
mers of L-1,4-N-acetyl-D-glucosamine. This chitin-binding ac-
tivity apparently relies on the presence of well-conserved ar-
omatic amino acids and the N-terminal pyroglutamate residue
[18]. It should be mentioned, however, that the chitin-binding
activity of Ee-CBP on its own cannot explain the inhibitory
activity towards Oomycetes (which do not contain chitin in
their cell wall) and Gram-positive bacteria [17]. Further re-
search on the mode of action of Ee-CBP will be required prior
to use of this AMP for genetically engineering purposes, either
alone or in combination with other plant defensive proteins.
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